English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Industrial Chemical General
Maculus Therapeutix欢迎Privity,为新型药物输送平台筹集资金
Feb 24, 2021 07:00 HKT
Maculus Therapeutix歡迎Privity,為新型藥物輸送平台籌集資金
Feb 24, 2021 07:00 HKT
Maculus Therapeutix welcomes Privity, Prepares Capital Raise for Novel Drug Delivery Platform
Feb 19, 2021 07:00 HKT
Showa Denko Revises Forecast of Consolidated Performance, and to Record Impairment Losses (Extraordinary Losses)
Feb 12, 2021 10:00 HKT
Elastomers develop stronger bonds of attachment
Feb 12, 2021 01:00 HKT
Showa Denko Invests in AMI Automation
Feb 08, 2021 11:00 HKT
럭스 리서치, 2021년에 주목할 만한 기술 순위를 발표
Feb 04, 2021 08:00 HKT
Materials coloured like a peacock
Jan 26, 2021 01:00 HKT
The Executive Talk: PTT Global Chemical PCL (SET:PTTGC)
Jan 20, 2021 13:00 HKT
Azelis Acquires Majority Shareholding in MKVN Chemicals and Viet Chemi
Jan 06, 2021 15:20 HKT
Azelis significantly increases its market presence in Vietnam through the acquisition of a majority shareholding in MKVN Chemicals and Viet Chemi
Jan 05, 2021 14:35 HKT
Sự hiện diện của Azelis trên thị trường Việt Nam đã được củng cố sâu sắc sau thương vụ thu mua đa số cổ phần tại MKVN Chemicals và Viet Chemi
Jan 05, 2021 14:30 HKT
Showa Denko Establishes Joint Corporation in Sichuan, China to Manufacture High-purity Gas for Electronics
Nov 06, 2020 15:00 HKT
田中贵金属:“2020年度 催化剂工业协会技术奖”获奖
Nov 05, 2020 10:00 HKT
TANAKA Receives 2020 Technology Award from Catalyst Manufacturers Association, Japan
Oct 29, 2020 10:00 HKT
Mitsubishi Chemical: Has developed new electrolyte for Tesla. The solvents and solute are supplied from Shida Shenghua
Sep 20, 2020 13:13 HKT
The sole supplier of solvents and additives in Tesla's new battery is Chinese company Shi Dashenghua
Sep 17, 2020 16:40 HKT
TANAKA Wins Award in Industry of FY2019 FCDIC Honoring System
Sep 10, 2020 10:00 HKT
阿泽雷斯发布第一份可持续发展报告,以表明为全球可持续发展做出的努力
Aug 12, 2020 16:00 HKT
阿澤雷斯發布第一份可持續發展報告,以表明為全球可持續發展做出的努力
Aug 12, 2020 16:00 HKT
Next >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: